71 related articles for article (PubMed ID: 38622549)
1. Integration of Hepatitis C and Addiction Treatment in People Who Inject Drugs: The San Patrignano HCV-Free and Drug-Free Experience.
Piselli P; Boschini A; Gianfreda R; Nappo A; Cimaglia C; Scarfò G; Smacchia C; Paoletti R; Duehren S; Girardi E
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543741
[TBL] [Abstract][Full Text] [Related]
2. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs.
Sulkowski MS; Martinez A; Tyson GL; Scholz K; Franco RA; Kohli A; Julius SF; Deming P; Fink SA; Lynch K; Roytman M; Stainbrook TR; Turner MD; Viera-Briggs M; Ramers CB
J Viral Hepat; 2024 Jun; 31(6):342-356. PubMed ID: 38433561
[TBL] [Abstract][Full Text] [Related]
3. Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience.
Torre P; Coppola R; Masarone M; Persico M
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005877
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Knowledge and Self-Reported Testing Behavior in the General Population in China: Online Cross-Sectional Survey.
Liu Y; Su J; Wang X; Xu H; Wang H; Kang R; Zheng L; Wang Y; Liu C; Jing Y; Zhang S
JMIR Public Health Surveill; 2023 Dec; 9():e39472. PubMed ID: 38079213
[TBL] [Abstract][Full Text] [Related]
5. Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
Carlucci JG; Farooq SA; Sizemore L; Rickles M; Cosley B; McCormack L; Wester C
PLoS One; 2017; 12(11):e0188624. PubMed ID: 29190748
[TBL] [Abstract][Full Text] [Related]
6. The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination.
Kapadia SN; Jordan AE; Eckhardt BJ; Perlman DC
Clin Infect Dis; 2024 May; 78(5):1235-1239. PubMed ID: 37633653
[TBL] [Abstract][Full Text] [Related]
7. Impact of Public Policy and COVID-19 Pandemic on Hepatitis C Testing and Treatment in France, 2014-2021.
Brouard C; Schwager M; Expert A; Drewniak N; Laporal S; de Lagasnerie G; Lot F
Viruses; 2024 May; 16(5):. PubMed ID: 38793673
[TBL] [Abstract][Full Text] [Related]
8. Review of the U.S. Air Force Academy Hepatitis C Virus Screening Program to Ensure High-Value Care.
Kelly DC; Webber B
Mil Med; 2024 Jun; ():. PubMed ID: 38836610
[TBL] [Abstract][Full Text] [Related]
9. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies.
Mousavi S; Alavi M; Delavari A; Poustchi H; Mohammadi Z; Malekzadeh R
J Viral Hepat; 2024 Jun; ():. PubMed ID: 38831601
[TBL] [Abstract][Full Text] [Related]
10. US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for National HCV Elimination though Patient-Centered Medical Homes.
Litwin AH; Akiyama MJ
Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38279941
[No Abstract] [Full Text] [Related]
11. Early treatment of acute or recently acquired hepatitis C - an important tool on the path to HCV elimination!
Cornberg M; Wedemeyer H
Hepatology; 2024 Jun; ():. PubMed ID: 38836641
[No Abstract] [Full Text] [Related]
12. The obstacle is the way: Finding a path to hepatitis C elimination.
Lo Re V; Price JC; Schmitt S; Terrault N; Bhattacharya D; Aronsohn A
Hepatology; 2024 May; ():. PubMed ID: 38752360
[No Abstract] [Full Text] [Related]
13. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
14. From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
Kondili LA; Craxì L; Nava F; Babudieri S; D'Ambrosio R; Marcellusi A; Mennini FS; Valle S; Russo P; Olimpieri PP; Andreoni M; Aghemo A
J Infect Dis; 2023 Sep; 228(Suppl 3):S211-S220. PubMed ID: 37703346
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
16. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.
Tai CM; Yu ML
Kaohsiung J Med Sci; 2024 Feb; 40(2):112-118. PubMed ID: 38010851
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets.
Petkevičienė J; Voeller A; Čiupkevičienė E; Razavi-Shearer D; Liakina V; Jančorienė L; Kazėnaitė E; Zaksas V; Urbonas G; Kupčinskas L
BMC Public Health; 2024 Apr; 24(1):1055. PubMed ID: 38622549
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
